Our Team

Margaret Vernon, Ph.D., serves as Chief Executive Officer of Biologics Consulting Group. In this role, she has global strategic leadership and P&L responsibilities for Biologics’ clinical and non-clinical, CMC, devices, project management and publishing consulting practices and services. She also oversees all operations and personnel in the organization.

Dr. Vernon is a subject matter expert regarding patient-reported outcome (PRO) instrument development and validation programs with a special interest in measurement in rare diseases. She has expertise in regulatory strategy and PRO clinical trial implementation and analysis, as well as significant experience and formal training in both qualitative and quantitative methods.

Margaret was previously Senior Vice President and General Manager for the Evidera Advisory Business Unit within the PPD clinical research business of Thermo Fisher Scientific. In this role, she had global executive leadership and P&L responsibilities for Evidera’s combined consulting practices (data and analytics, evidence synthesis, modeling and communication, development and value/access consulting, as well as patient-centered research, medical writing and health care communications).

Prior to joining Evidera, she began her career as a research psychologist with the U.S. Bureau of Labor Statistics.

Margaret earned a Bachelor of Science in psychology from the University of Illinois at Urbana-Champaign and a Ph.D. in psychology with a concentration in research methods and statistics from Pennsylvania State University.